Trevena, Inc.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein bi…
Biotechnology
US, Chesterbrook [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Trevena, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDTrevena, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Trevena, Inc..
If you want to see a demo, head over to the financial segments of AAPL